NALOXONE AMELIORATES THE PRURITUS OF CHOLESTASIS - RESULTS OF A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL

被引：0
|
作者：
BERGASA, NV
ALLING, DW
TALBOT, TL
SWAIN, MG
FRIED, MW
FONG, TL
YURDAYDIN, C
SCHMITT, JM
WALKER, EC
TURNER, ML
JONES, EA
机构：
[1] NIDDK,LIVER DIS SECT,BETHESDA,MD
[2] NIAID,DIV INTRAMURAL RES,BETHESDA,MD 20892
[3] NIH,APPL CLIN ENGN SECT,BETHESDA,MD 20892
来源：
HEPATOLOGY | 1992年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A152 / A152
页数：1
相关论文
共 50 条
  • [1] Gabapentin in patients with the pruritus of cholestasis: A double-blind, randomized, placebo-controlled trial
    Bergasa, Nora V.
    McGee, Monnie
    Ginsburg, Iona H.
    Engler, Danielle
    [J]. HEPATOLOGY, 2006, 44 (05) : 1317 - 1323
  • [2] NALMEFENE THERAPY IS ASSOCIATED WITH THE RELIEF OF THE PRURITUS OF CHOLESTASIS - RESULTS OF A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL
    BERGASA, NV
    ALLING, DW
    TALBOT, TL
    CHIA, SC
    SOUPPAYA, M
    CONJEEVARAM, H
    SALLIE, R
    YURDAYDIN, C
    WELLS, M
    SWAIN, MG
    DIBISCEGLIE, AM
    HOOFNAGLE, JH
    JONES, EA
    [J]. HEPATOLOGY, 1993, 18 (04) : A177 - A177
  • [3] EFFECTS OF NALOXONE INFUSIONS IN PATIENTS WITH THE PRURITUS OF CHOLESTASIS - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL
    BERGASA, NV
    ALLING, DW
    TALBOT, TL
    SWAIN, MG
    YURDAYDIN, C
    TURNER, ML
    SCHMITT, JM
    WALKER, EC
    JONES, EA
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (03) : 161 - 167
  • [4] Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial
    Gunal, AI
    Ozalp, G
    Yoldas, TK
    Gunal, SY
    Kirciman, E
    Celiker, H
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (12) : 3137 - 3139
  • [5] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    [J]. OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
  • [6] Pharmacological challenge with naloxone and cue exposure in alcohol dependence: Results of a randomized, double-blind placebo-controlled trial
    Lieb, Martin
    Palm, Ulrich
    Chiang, Sonnig
    Laubender, Ruediger P.
    Nothdurfter, Caroline
    Sarubin, Nina
    Mokhtari-Nejad, Rabee
    Koller, Gabriele
    Soyka, Michael
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2013, 14 (07): : 539 - 546
  • [7] The effectiveness of combined naloxone/lofexidine in opiate detoxification: Results from a double-blind randomized and placebo-controlled trial
    Beswick, T
    Best, D
    Bearn, J
    Gossop, M
    Rees, S
    Strang, J
    [J]. AMERICAN JOURNAL ON ADDICTIONS, 2003, 12 (04): : 295 - 305
  • [8] OXATOMIDE IN THE TREATMENT OF PRURITUS SENILIS - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    DUPONT, C
    DEMAUBEUGE, J
    KOTLAR, W
    LAYS, Y
    MASSON, M
    [J]. DERMATOLOGICA, 1984, 169 (06): : 348 - 353
  • [9] Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial
    Pariser, David M.
    Bagel, Jerry
    Lebwohl, Mark
    Yosipovitch, Gil
    Chien, Elaine
    Spellman, Mary C.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (06) : 1314 - 1320
  • [10] A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus
    Mathur, Vandana S.
    Kumar, Jayant
    Crawford, Paul W.
    Hait, Howard
    Sciascia, Thomas
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2017, 46 (06) : 450 - 458
12345